Literature DB >> 20207197

The increasing recognition of rickettsial pathogens in dogs and people.

William L Nicholson1, Kelly E Allen, Jennifer H McQuiston, Edward B Breitschwerdt, Susan E Little.   

Abstract

Dogs and people are exposed to and susceptible to infection by many of the same tick-borne bacterial pathogens in the order Rickettsiales, including Anaplasma phagocytophilum, Ehrlichia canis, E. chaffeensis, E. ewingii, Rickettsia rickettsii, R. conorii, and other spotted fever group rickettsiae. Recent findings include descriptions of novel Ehrlichia and Rickettsia species, recognition of the occurrence and clinical significance of co-infection, and increasing awareness of Rhipicephalus sanguineus-associated diseases. Newer molecular assays are available, although renewed efforts to encourage their use are needed. This review highlights the ecology and epidemiology of these diseases, and proposes avenues for future investigation. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20207197     DOI: 10.1016/j.pt.2010.01.007

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  66 in total

1.  The prevalence of zoonotic tick-borne pathogens in Ixodes scapularis collected in the Hudson Valley, New York State.

Authors:  Matthew T Aliota; Alan P Dupuis; Michael P Wilczek; Ryan J Peters; Richard S Ostfeld; Laura D Kramer
Journal:  Vector Borne Zoonotic Dis       Date:  2014-04-01       Impact factor: 2.133

2.  Serologic assessment for exposure to spotted fever group rickettsiae in dogs in the Arizona-Sonora border region.

Authors:  Hayley D Yaglom; William L Nicholson; Mariana Casal; Nathan C Nieto; Laura Adams
Journal:  Zoonoses Public Health       Date:  2018-08-21       Impact factor: 2.702

Review 3.  One health: the importance of companion animal vector-borne diseases.

Authors:  Michael J Day
Journal:  Parasit Vectors       Date:  2011-04-13       Impact factor: 3.876

4.  Sensitivity and specificity levels of two rapid assays for antibodies to Anaplasma spp. in dogs.

Authors:  Jiayou Liu; Matthew Eberts; Hannah Bewsey; Thomas P O'Connor; Ramaswamy Chandrashekar; Edward B Breitschwerdt
Journal:  J Vet Diagn Invest       Date:  2017-12-04       Impact factor: 1.279

Review 5.  Delayed anaphylaxis to red meat in patients with IgE specific for galactose alpha-1,3-galactose (alpha-gal).

Authors:  Scott P Commins; Thomas A E Platts-Mills
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

6.  Rickettsia conorii infection stimulates the expression of ISG15 and ISG15 protease UBP43 in human microvascular endothelial cells.

Authors:  Punsiri M Colonne; Abha Sahni; Sanjeev K Sahni
Journal:  Biochem Biophys Res Commun       Date:  2011-11-11       Impact factor: 3.575

7.  Evolution of antigen variation in the tick-borne pathogen Anaplasma phagocytophilum.

Authors:  Daniel Rejmanek; Patrick Foley; Anthony Barbet; Janet Foley
Journal:  Mol Biol Evol       Date:  2011-09-28       Impact factor: 16.240

8.  Comparative Efficacy of an Imidacloprid/Flumethrin Collar (Seresto®) and an Oral Afoxolaner Chewable (NexGard®) against Tick (Dermacentor variabilis and Amblyomma americanum) Infestations on Dogs: a Randomised Controlled Trial.

Authors:  Cameon M Ohmes; Joe Hostetler; Wendell L Davis; Terry Settje; William R Everett
Journal:  Parasitol Res       Date:  2015-08       Impact factor: 2.289

9.  Detection of a Novel Ehrlichia Species in Haemaphysalis longicornis Tick from China.

Authors:  Limei Luo; Jimin Sun; Jianbo Yan; Chengwei Wang; Zhentang Zhang; Li Zhao; Huiju Han; Zhendong Tong; Miaomiao Liu; Yuyan Wu; Hongling Wen; Rong Zhang; Zaifeng Xue; Xifeng Sun; Kefeng Li; Dongqiang Ma; Jianwei Liu; Yuting Huang; Ling Ye; Wenqian Li; Jianmin Jiang; Xue-Jie Yu
Journal:  Vector Borne Zoonotic Dis       Date:  2016-05-02       Impact factor: 2.133

10.  Recent research milestones in the pathogenesis of human rickettsioses and opportunities ahead.

Authors:  Hema P Narra; Abha Sahni; David H Walker; Sanjeev K Sahni
Journal:  Future Microbiol       Date:  2020-07-21       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.